期刊文献+

肺炎支原体对大环内酯类抗生素的耐药机制 被引量:47

在线阅读 下载PDF
导出
摘要 肺炎支原体(MP)是儿童和青少年社区获得性呼吸道感染的常见病原体,大环内酯类抗生素是治疗小儿MP感染的首选药物。然而,近年来MP对大环内酯类抗生素出现耐药,结合位点的基因突变是目前的研究热点,也是引起MP耐药的主要机制之一。对MP耐药性的研究可为抗生素的合理选择和应用提供理论指导。
作者 韩旭 辛德莉
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2006年第16期1101-1103,共3页 Journal of Applied Clinical Pediatrics
基金 国家自然科学基金项目资助(30571973)
作者简介 韩旭,女,硕士生,研究方向为肺炎支原体感染。 [通讯作者]辛德莉,女,主任医师,硕士学位,研究方向为呼吸系统疾病。
  • 相关文献

参考文献20

  • 1汤文红,曹秀章.小儿呼吸道肺炎支原体感染发病趋势及临床分析[J].临床儿科杂志,2005,23(8):562-563. 被引量:96
  • 2Bebear CM,Pereyre S.Mechanisms of drug resistance in Mycoplasma pneumoniae[J].Curr Drug Targets-Infect Dis,2005,5:263 -271.
  • 3Okazaki N,Narita M,Yamada S,et al.Characteristic of macrolideresistant Mycoplasma pneumoniae strains isolated from patients and induced with Erythromycin in vitro[J].Microbiol Immunol,2001,45(8):617-620.
  • 4辛德莉,侯安存,魏田力,李靖,马红秋.肺炎支原体对大环内酯类抗生素耐药的分析[J].中华儿科杂志,2005,43(3):212-212. 被引量:85
  • 5Matsuoka M,Narita M,Okazaki N,et al.Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in japan[J].Antimicrob Agents Chemother,2004,48 (12):4624-4630.
  • 6Ban N,Nissen P,Hansen J,et al.The complete atomatic structure of the large ribosomal subunit at 2.4(A) resolution[J].Science,2000,289(11):905-920.
  • 7Wilson DN,Harms JM,Nierhaus KH,et al.Species-specific antibiotic-ribosome interactions:Implications for drug development[J].Biol Chem,2005,386 (12):1239-1252.
  • 8Harms JM,Bartels H,Schlunzen F,et al.Antibiotics acting on the translational machinery[j].J Cell Sci,2003,116:1391-1393.
  • 9Vester B,Douthwaite S.Macrolide resistance conferred by base substitutions 23S rRNA[J].Antimicrob Agents Chemother,2001,45(1):1-12.
  • 10Hansen JL,Ippolito JA,Ban N,et al.The structures of four macrolide antibiotics bound to the large ribosomal subunit[J].Mol Cell,2002,10:117-128.

二级参考文献62

  • 1杨慧,沈叙庄,王咏红,袁林,俞桑洁,杨永弘.北京地区儿童鼻咽部肺炎链球菌对大环内酯类抗生素耐药的检测[J].中华儿科杂志,2004,42(12):936-939. 被引量:9
  • 2辛德莉,李贵,张继红,张小为,王黛,许淑贞,陈湘.聚合酶链反应在肺炎支原体检测中的临床应用与研究[J].中华儿科杂志,1994,32(5):296-297. 被引量:44
  • 3[1]Edelstein PH. Pneumococcal resistance to macrolides, lincosamides,ketolides, and streptogramin B agents: molecular mechanisms and resistance phenotypes[J]. Clin Infect Dis ,2004 ,38 ( Suppl 4): S322 ~ 7
  • 4[2]Jacobs MR, Felmingham D, Appelbaum PC, et al. The Alexander Project Group. The Alexander Project 1998 ~ 2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents[J]. J Antimicrob Chemother,2003,52(2) :229 ~46
  • 5[3]Gordon KA, Biedenbach DJ, Jones RN. Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections SENTRY Antimicrobial Surveillance Program[ J]. Diagn Microbiol Infect Dis,2003,46(4) :285 ~9
  • 6[4]Waites K, Brown S. Antimicrobial resistance among isolates of respiratory tract infection pathogens from the southern United States:data from the PROTEKT US Surveillance Program 2000/2001[J].South Med J,2003,96(10) :974 ~ 85
  • 7[5]Grosso MD,Iannelli F,Messina C,et al. Macrolide efflux genes mef(A)and mef(E) are carried by different genetic elements in Streptococcus pneumoniae[J]. J Clin Microbiol,2002,40(3):774~8
  • 8[6]Song JH, Chang HH, Suh JY, et al. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP) [J]. J Antimicrob Chemother,2004,53(3):457 ~ 63.
  • 9[7]Farrell DJ, I Morrissey, S Bakker, et al. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study[J]. J Antimicrob Chemother,2002 ,50( Suppl. S1 ) :39 ~47
  • 10[10]Lynch JP, Martinez FJ. Clinical relevance of macrolide-resistant Streptococcus pneumoniae forcommunity-acquired pneumonia[J].Clin Infect Dis,2002,34 ( Suppl 1 ): S27 ~ S46

共引文献221

同被引文献362

引证文献47

二级引证文献627

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部